…
Premier, Inc., together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions. This segment also provides the ASCENDrive programs for members to receive group purchasing programs, tiers, and prices; SURPASS Performance Group services; and STOCKD, an e-commerce platform, as well as direct sourcing business; SaaS informatics products; supply chain co-management services; purchased services contracts; direct sourcing solutions; and supply chain resiliency programs. The Performance Services segment provides technology and services platform with offerings that help optimize performance in three main areas, including clinical intelligence, margin improvement, and value-based care under the PINC AI brand; third party administrator services and management of health benefit programs under the Contigo Health brand; and digital invoicing and payables services that offers financial support services to healthcare product suppliers and service providers under the Remitra brand. The company was incorporated in 2013 and is based in Charlotte, North Carolina.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Premier Inc. provides group purchasing, supply‑chain, data analytics and advisory services to U.S. hospitals and health systems. Long-term growth drivers include pressure on providers to lower costs, wider adoption of analytics and technology-enabled services, and recurring contract revenue from a large provider network that may support margin improvement.
Principal risks include regulatory and reimbursement changes, competition from other GPOs and technology vendors, and execution risk when scaling integrated services.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Income before tax | 250.00M | 326.90M | 250.64M | 383.69M | 368.14M |
| Minority interest | 0.14M | 2.45M | 17.06M | 161.82M | 174.96M |
| Net income | 175.03M | 265.87M | 287.52M | 291.13M | 334.68M |
| Selling general administrative | 611.03M | 601.13M | 572.70M | 670.59M | 662.46M |
| Selling and marketing expenses | -9.48M | -24.25M | -40.37M | -210.73M | 223.48M |
| Gross profit | 896.29M | 885.04M | 837.33M | 866.80M | 862.01M |
| Reconciled depreciation | 133.79M | 129.11M | 121.06M | 152.83M | 140.16M |
| Ebit | 264.47M | 260.07M | 256.92M | 373.62M | 368.51M |
| Ebitda | 398.26M | 403.04M | 411.02M | 521.76M | 515.36M |
| Depreciation and amortization | 133.79M | 142.97M | 154.10M | 148.14M | 146.84M |
| Non operating income net other | 7.91M | 66.83M | -6.28M | 10.07M | -0.38M |
| Operating income | 242.09M | 260.07M | 256.92M | 373.62M | 368.51M |
| Other operating expenses | 1094.00M | 1172.83M | 1464.23M | 925.97M | 849.12M |
| Interest expense | 14.47M | 11.14M | 11.96M | 11.31M | 2.47M |
| Tax provision | 75.11M | 58.58M | -53.94M | 92.56M | 33.46M |
| Interest income | - | - | - | - | 3.19M |
| Net interest income | -14.47M | -11.14M | -11.96M | -11.31M | -2.47M |
| Extraordinary items | - | - | - | - | -234.55M |
| Income tax expense | 75.11M | 58.58M | -53.94M | 92.56M | 33.46M |
| Total revenue | 1336.10M | 1432.90M | 1721.15M | 1299.59M | 1217.64M |
| Total operating expenses | 654.20M | 624.97M | 580.42M | 493.18M | 493.49M |
| Cost of revenue | 439.81M | 547.86M | 883.82M | 432.79M | 355.63M |
| Total other income expense net | 22.38M | 66.83M | -6.28M | 10.07M | -0.38M |
| Discontinued operations | - | - | - | 0.56M | -24.65M |
| Net income from continuing ops | 174.89M | 268.32M | 304.58M | 291.13M | 334.68M |
| Net income applicable to common shares | 175.03M | 265.87M | 304.58M | 598.67M | -8.94M |
| Preferred stock and other adjustments | - | - | 26.68M | -468.31M | 118.06M |
| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Total assets | 3371.49M | 3357.13M | 3522.90M | 2948.51M | 2569.57M |
| Intangible assets | 430.03M | 356.57M | 396.64M | 417.42M | 270.72M |
| Other current assets | 60.39M | 325.64M | 68.05M | 97.34M | 27.15M |
| Total liab | 1037.13M | 1108.28M | 1293.01M | 2809.25M | 3431.82M |
| Total stockholder equity | 2334.36M | 2248.85M | 2229.89M | 139.26M | -862.25M |
| Deferred long term liab | 27.91M | 23.79M | 23.18M | 20.74M | 19.54M |
| Other current liab | 420.57M | 427.18M | 423.07M | 326.23M | 340.25M |
| Common stock | 1.26M | 1.25M | 1.23M | 0.72M | 0.64M |
| Capital stock | 1.26M | 1.25M | 1.23M | 0.72M | 0.64M |
| Retained earnings | 405.10M | 331.69M | 169.47M | 0.00M | -775.67M |
| Other liab | 97.55M | 2603.99M | 527.79M | 2255.55M | 2967.79M |
| Good will | 1012.36M | 999.91M | 999.91M | 941.97M | 880.71M |
| Other assets | 814.09M | 886.62M | 918.35M | 572.88M | 499.35M |
| Cash | 89.79M | 86.14M | 129.14M | 99.30M | 141.06M |
| Total current liabilities | 815.46M | 753.14M | 716.78M | 496.07M | 458.02M |
| Current deferred revenue | 24.31M | 30.46M | 34.06M | 35.45M | 35.62M |
| Net debt | 350.54M | 401.14M | 392.53M | 37.89M | -107.44M |
| Short term debt | 316.21M | 250.86M | 174.24M | 79.56M | 27.61M |
| Short long term debt | 316.21M | 250.86M | 174.24M | 79.56M | 27.61M |
| Short long term debt total | 440.33M | 487.29M | 521.67M | 137.19M | 33.61M |
| Other stockholder equity | 1928.01M | 1915.92M | 2059.19M | 138.55M | -87.22M |
| Property plant equipment | 212.31M | 252.91M | 272.47M | 104.95M | 45.51M |
| Total current assets | 641.63M | 645.57M | 782.30M | 618.36M | 614.04M |
| Long term investments | 231.83M | 215.54M | 153.22M | 133.34M | 99.64M |
| Net tangible assets | 2334.36M | -1356.48M | 833.34M | -1379.72M | -2173.28M |
| Short term investments | - | - | 153.22M | - | - |
| Net receivables | 414.51M | 374.19M | 408.73M | 350.72M | 394.81M |
| Long term debt | 102.26M | 2.28M | 304.33M | 4.64M | 6.00M |
| Inventory | 76.93M | 119.65M | 176.38M | 71.00M | 51.03M |
| Accounts payable | 54.38M | 44.63M | 85.41M | 54.84M | 54.54M |
| Accumulated other comprehensive income | -0.01M | -0.00M | - | -452.61M | -359.24M |
| Common stock total equity | 1.26M | 1.25M | 1.23M | 0.72M | 0.64M |
| Retained earnings total equity | 405.10M | 331.69M | 169.47M | - | -775.67M |
| Treasury stock | - | -250.13M | - | - | -87.22M |
| Non currrent assets other | 160.46M | 161.59M | 136.53M | 142.85M | 77.33M |
| Non current assets total | 2729.86M | 2711.56M | 2740.60M | 2330.15M | 1955.52M |
| Capital lease obligations | 21.86M | 32.96M | 43.10M | 52.99M | - |
| Long term debt total | 102.26M | 2.28M | - | 284.62M | 6.00M |
| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Investments | -273.62M | -16.00M | -174.57M | -10.16M | -7.88M |
| Change to liabilities | -19.59M | -70.67M | 134.08M | -30.35M | 22.14M |
| Total cashflows from investing activities | -273.62M | -139.44M | -174.57M | -222.32M | -129.47M |
| Net borrowings | -35.86M | -24.24M | -50.71M | 47.58M | -75.68M |
| Total cash from financing activities | -167.27M | -347.79M | -203.00M | -168.95M | -387.20M |
| Change to operating activities | - | - | - | - | 18.90M |
| Net income | 174.89M | 268.32M | 304.58M | 291.13M | 334.68M |
| Change in cash | 3.65M | -43.00M | 29.84M | -41.75M | -11.33M |
| Begin period cash flow | 86.14M | 129.14M | 99.30M | 141.06M | 152.39M |
| End period cash flow | 89.79M | 86.14M | 129.14M | 99.30M | 141.06M |
| Total cash from operating activities | 444.54M | 444.23M | 407.40M | 349.52M | 505.34M |
| Depreciation | 133.79M | 129.11M | 121.06M | 152.83M | 140.16M |
| Other cashflows from investing activities | -189.26M | -36.00M | -1.23M | -117.76M | -28.21M |
| Dividends paid | -100.23M | -96.45M | -102.85M | -48.90M | 57.83M |
| Change to inventory | - | - | - | - | 1.60M |
| Change to account receivables | 64.25M | 124.66M | -68.01M | -121.73M | -6.70M |
| Sale purchase of stock | 6.08M | -250.13M | 0.00M | -150.09M | -258.27M |
| Other cashflows from financing activities | 438.83M | 310.27M | 175.56M | -17.54M | -17.72M |
| Change to netincome | 132.29M | 40.04M | -15.57M | 89.39M | 88.68M |
| Capital expenditures | 82.30M | 87.44M | 88.88M | 94.40M | 93.39M |
| Cash flows other operating | 23.16M | 77.44M | -119.69M | -154.52M | -31.33M |
| Cash and cash equivalents changes | 3.65M | -42.99M | 29.84M | -41.75M | -11.33M |
| Change in working capital | 3.58M | 6.77M | 14.39M | -160.29M | -7.58M |
| Stock based compensation | 13.73M | 46.23M | 35.42M | 20.71M | 29.00M |
| Other non cash items | 47.15M | -62.98M | 15.64M | -22.82M | -2.80M |
| Free cash flow | 362.24M | 356.79M | 318.53M | 255.13M | 411.95M |
Sector: Healthcare Industry: Health Information Services
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| PINC PGIM Securitized Income ETF |
-0.00 0.01% |
49.22 | 27.90 | 9.28 | 1.92 | 1.06 | 1.77 | 6.22 |
| VEEV Veeva Systems Inc Class A |
-4.88 1.60% |
299.89 | 43.49 | 29.59 | 12.48 | 5.79 | 10.39 | 33.41 |
| PMCUF Pro Medicus Limited |
0.68 0.48% |
142.50 | 64.90 | 90.91 | 49.11 | 38.05 | 65.12 | 83.47 |
| TEM Tempus AI, Inc. Class A Common Stock |
-4.81 6.06% |
74.62 | - | - | 8.68 | 25.39 | 8.33 | - |
| MTHRY M3 Inc |
-0.07 1.22% |
5.66 | 31.84 | 26.25 | 0.05 | 4.60 | 0.04 | 0.12 |
Premier, Inc., together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions. This segment also provides the ASCENDrive programs for members to receive group purchasing programs, tiers, and prices; SURPASS Performance Group services; and STOCKD, an e-commerce platform, as well as direct sourcing business; SaaS informatics products; supply chain co-management services; purchased services contracts; direct sourcing solutions; and supply chain resiliency programs. The Performance Services segment provides technology and services platform with offerings that help optimize performance in three main areas, including clinical intelligence, margin improvement, and value-based care under the PINC AI brand; third party administrator services and management of health benefit programs under the Contigo Health brand; and digital invoicing and payables services that offers financial support services to healthcare product suppliers and service providers under the Remitra brand. The company was incorporated in 2013 and is based in Charlotte, North Carolina.
13034 Ballantyne Corporate Place, Charlotte, NC, United States, 28277
704 357 0022
2800
| Name | Title | Year Born |
|---|---|---|
| Mr. Michael J. Alkire | Pres, CEO & Director | 1963 |
| Mr. Craig Steven McKasson | Chief Admin. Officer, CFO, Sr. VP & Treasurer | 1967 |
| Mr. David L. Klatsky J.D. | Gen. Counsel | 1962 |
| Mr. Leigh T. Anderson | Pres of Performance Services | 1967 |
| Mr. David Alfred Hargraves | Sr. VP of Supply Chain | 1969 |
| Ms. Crystal Climer | Chief Accounting Officer | NA |
| Ms. Angeline C. McCabe | VP of Investor Relations | NA |
| Ms. Kaycee Kalpin | Chief Marketing Officer | NA |
| Ms. Susan Dodson DeVore | Advisor | 1959 |
| Mr. Andy Brailo | Chief Customer Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.